Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 11.40%6.37B | 14.90%1.74B | 7.82%1.65B | 10.64%1.56B | 12.40%1.41B | 29.29%5.72B | 14.02%1.52B | 19.11%1.53B | 38.17%1.41B | 60.24%1.26B |
Operating revenue | 11.40%6.37B | 14.90%1.74B | 7.82%1.65B | 10.64%1.56B | 12.40%1.41B | 29.29%5.72B | 14.02%1.52B | 19.11%1.53B | 38.17%1.41B | 60.24%1.26B |
Cost of revenue | 10.45%5.66B | 14.55%1.56B | 7.00%1.45B | 9.62%1.38B | 10.56%1.28B | 29.37%5.13B | 15.58%1.36B | 20.05%1.36B | 34.94%1.26B | 58.97%1.16B |
Gross profit | 19.70%703.25M | 17.88%184.6M | 14.18%198.56M | 18.72%186.71M | 33.73%133.38M | 28.59%587.49M | 2.10%156.6M | 12.26%173.9M | 70.74%157.26M | 76.56%99.73M |
Operating expense | 16.61%383.35M | 19.55%96.54M | 16.23%98.11M | 17.00%100.12M | 13.56%88.59M | 16.75%328.73M | -10.94%80.75M | 11.47%84.4M | 43.26%85.57M | 40.67%78.01M |
Selling and administrative expenses | 16.61%383.35M | 19.55%96.54M | 16.23%98.11M | 17.00%100.12M | 13.56%88.59M | 16.75%328.73M | -10.94%80.75M | 11.47%84.4M | 43.26%85.57M | 40.67%78.01M |
Operating profit | 23.63%319.89M | 16.09%88.06M | 12.25%100.46M | 20.78%86.59M | 106.18%44.79M | 47.60%258.76M | 20.95%75.85M | 13.01%89.49M | 121.42%71.69M | 2,006.98%21.72M |
Net non-operating interest income expense | 16.45%-65.32M | 43.25%-12.33M | 15.22%-17.86M | -1.47%-17.13M | 2.56%-17.99M | -99.35%-78.17M | -17.09%-21.73M | -61.11%-21.07M | -258.85%-16.88M | -542.04%-18.47M |
Non-operating interest expense | -16.45%65.32M | -43.25%12.33M | -15.22%17.86M | 1.47%17.13M | -2.56%17.99M | 99.35%78.17M | 17.09%21.73M | 61.11%21.07M | 258.85%16.88M | 542.04%18.47M |
Other net income (expense) | 111.58%338K | 139.28%425K | 52.91%-291K | 67.54%320K | 91.93%-116K | -112.58%-2.92M | -183.29%-1.08M | 95.34%-618K | -99.46%191K | -220.98%-1.44M |
Gain on sale of security | 129.92%2.67M | 679.71%800K | 55,400.00%553K | 102.39%761K | -39.52%560K | 6.89%1.16M | -110.40%-138K | 99.85%-1K | -32.86%376K | 898.28%926K |
Special income (charges) | 57.04%-2.44M | 53.87%-465K | 16.51%-905K | 41.87%-522K | 79.59%-550K | -128.38%-5.69M | 44.80%-1.01M | 91.47%-1.08M | -102.57%-898K | -734.37%-2.7M |
-Less:Restructuring and merger&acquisition | -57.04%2.44M | -53.87%465K | -16.51%905K | -41.87%522K | -79.59%550K | -71.65%5.69M | -44.80%1.01M | -91.47%1.08M | -82.73%898K | 734.37%2.7M |
-Gain on sale of property,plant,equipment | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Other non- operating income (expenses) | -93.39%106K | 40.63%90K | -86.94%61K | -88.64%81K | -138.07%-126K | -22.59%1.6M | -96.44%64K | 264.84%467K | 360.00%713K | 3,777.78%331K |
Income before tax | 43.48%254.92M | 43.57%76.15M | 21.38%82.31M | 26.87%69.78M | 1,365.93%26.68M | 11.54%177.67M | 16.69%53.04M | 28.30%67.81M | -13.08%55M | 179.37%1.82M |
Income tax | 43.68%74.03M | 44.24%22.19M | 21.38%23.87M | 26.73%20.24M | 1,417.06%7.74M | 96.17%51.52M | 289.02%15.38M | 100.45%19.66M | 21.71%15.97M | 182.39%510K |
Net income | 43.40%180.89M | 43.30%53.97M | 21.38%58.44M | 26.93%49.54M | 1,346.03%18.94M | -5.17%126.15M | -9.26%37.66M | 11.86%48.14M | -22.18%39.03M | 178.26%1.31M |
Net income continuous Operations | 43.40%180.89M | 43.30%53.97M | 21.38%58.44M | 26.93%49.54M | 1,346.03%18.94M | -5.17%126.15M | -9.26%37.66M | 11.86%48.14M | -22.18%39.03M | 178.26%1.31M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 43.40%180.89M | 43.30%53.97M | 21.38%58.44M | 26.93%49.54M | 1,346.03%18.94M | -5.17%126.15M | -9.26%37.66M | 11.86%48.14M | -22.18%39.03M | 178.26%1.31M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 43.40%180.89M | 43.30%53.97M | 21.38%58.44M | 26.93%49.54M | 1,346.03%18.94M | -5.17%126.15M | -9.26%37.66M | 11.86%48.14M | -22.18%39.03M | 178.26%1.31M |
Basic earnings per share | 42.19%3.37 | 40.85%1 | 21.11%1.09 | 26.03%0.92 | 1,650.00%0.35 | -5.20%2.37 | -8.97%0.71 | 11.11%0.9 | -22.34%0.73 | 166.67%0.02 |
Diluted earnings per share | 42.06%3.31 | 43.48%0.99 | 20.22%1.07 | 26.39%0.91 | 1,650.00%0.35 | -5.67%2.33 | -10.39%0.69 | 11.25%0.89 | -22.58%0.72 | 166.67%0.02 |
Dividend per share | 8.33%0.26 | 33.33%0.08 | 0.00%0.06 | 0.00%0.06 | 0.00%0.06 | 0.00%0.24 | 0.00%0.06 | 0.00%0.06 | 0.00%0.06 | 0.00%0.06 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |